Vantage-OTC Labs · Studio · in-flight work

Each Vantage-OTC Labs widget rests on a category brief that maps active ingredients, OTC1–OTC4 tier per market, demand profile, sponsor map, and methodology. P1 briefs (the two below) feed Wave 1 widgets shipping 27 Oct 2026. Climate Category and earlier MPIF briefs live at the public-Labs `mpif-labs` surface; new briefs land here in Studio first.

P1 · WAVE 1 · FW

Cough · Cold · Flu

Draft v1

Respiratory category that powers Flu & Cough Watch™. Strepsils · Lemsip · Vicks · Sudafed · Otrivin. Reckitt master agreement is the highest-leverage sponsor move — covers 3–4 brands in one conversation.

3 markets 6 ingredients 2.5–3.2× multiplier Oct–Mar peak Reckitt anchor

Drafted · 22 May 2026 · placeholders for AFC + OTC1–OTC4 Open

P1 · WAVE 1 · QW

Smoking Cessation

Draft v1

N07BA nicotine-replacement category that powers Quit Watch™. NiQuitin · Nicotinell · Nicorette. Haleon owns 2 of 3 anchor brands · one master conversation covers two brands across all 3 markets. Jan 1 = biggest single-day NRT spike of the year.

3 markets 5 formats 4.8× multiplier Jan 1 + Stoptober Haleon anchor

Drafted · 22 May 2026 · placeholders for AFC + OTC1–OTC4 Open

Pipeline · category briefs · 4 more to draft

Sequenced by launch wave timing — see the launch plan for deadlines. Existing categories at `labs.vantage-otc.com` (Allergy · Analgesics · Digestive · Climate) are templates we reuse, not redo.

CAT · P2 · WAVE 2

Festive GI · Holiday Stomach

deadline mid-Oct 2026 · Gaviscon (Reckitt) anchor

CAT · P2 · WAVE 2

Weight Loss · diet

deadline mid-Oct 2026 · Alli (Haleon) anchor

CAT · P3 · WAVE 4

Sun · SPF · UV

deadline mid-Feb 2027 · Nivea (Beiersdorf) anchor

CAT · P4 · cross-module

Topical pain

flexible · Voltaren / Deep Heat / Tiger Balm

Already at `labs.vantage-otc.com` (now gated) · Allergy (feeds Pollen Pulse™) · Analgesics (systemic only · feeds cross-module) · Digestive · Climate · per-country MPIF assessments. Categories don't get re-drafted unless the doctrine changes.

02CSponsor pitches · critical-path outreach

Pitch documents drafted for review · cold approach until contact identified.

Sponsor signing is the longest critical-path item in the entire program (10–14 weeks per relationship). Drafts land here in Studio · founder reviews · approves · sends. First Reckitt email out by Wednesday 27 May = on critical path. Every week of slippage compresses the LOI buffer.

P1 · CRITICAL PATH · WAVE 1

Reckitt master agreement · 4 brands · 2 waves

Draft v1

The first and highest-leverage sponsor conversation. Strepsils · Lemsip · Nurofen Cold & Flu · Gaviscon. Includes the 1-pager, copy-ready intro email, 4-path cold-approach playbook with named target roles + LinkedIn search queries, and a 12-week decision tree from intro to signed LOI.

4 brands 2 waves €90k+ annual floor 12 wks sales cycle LOI by 13 Aug Cold approach

Drafted · 22 May 2026 · awaiting founder review + first send Open

P1 · WAVE 1 · QUEUED

Haleon master agreement · NiQuitin + Nicorette

Queued

Second master agreement · Haleon owns 2 of 3 Quit Watch™ anchor brands. Same template as Reckitt · uses Smoking Cessation category brief as backing. Begin drafting once Reckitt approach is sent.

2 brands 3 markets ~€54k annual Stoptober + Jan 1

Pending · draft starts week of 3 Jun 2026 — planned

Sponsor pitch pipeline · queued by wave urgency

Three more master agreements get drafted in sequence after Reckitt is in motion. Bayer Claritin is the second-highest leverage because Mar 2027 hayfever activation is "first-to-market" win condition.

PITCH · P2 · WAVE 3

Bayer · Claritin pollen sponsorship

draft Jul 2026 · activate Feb 2027 · first-to-market hayfever

PITCH · P3 · WAVE 1

P&G · Vicks + ZzzQuil

draft Jul 2026 · activate winter 2026/27 · single-parent leverage

PITCH · P4 · WAVE 4

Beiersdorf · Nivea Sun Shield™

draft Jan 2027 · activate May 2027 · single-product clean

PITCH · P5 · WAVE 2

Haleon · Alli Weight Reset Watch™

draft Sep 2026 · activate Dec 2026 · extends Haleon master

03Decisions pending · what's blocking

Five decisions sit between today and the foundation phase.

None of them are large or expensive. Most are 5-minute confirmations. They're listed so the founder can sweep them in one session and unblock the next two weeks of work.

Decisions awaiting founder · 2026-05-21

Ordered by criticality — top three are urgent (block start of Foundation phase), lower two have softer deadlines.

D1 · URGENT

Open Bayer (Claritin) outreach

Bayer sponsorship cycle is 6-9 months. To activate Pollen Pulse™ in Feb 2027, the first contact must go out in July 2026 latest. Founder makes intro.

D2 · URGENT

€30k tranche 1 commitment

First budget tranche covers Foundation phase: TM filings, brand mark, pricing validation, pitch deck, sponsor contract template. Six weeks of work, ~€25k of cost, ~€5k buffer.

D3 · URGENT

Confirm 7 module names final

Pollen Pulse™ · Sun Shield™ · Flu & Cough Watch™ · Holiday Stomach Watch™ · Sleep Rhythm Watch™ · Quit Watch™ · Weight Reset Watch™ — all 7 lock for trademark filing.

D4 · WARM

Engineering bench confirmed

2 FTE × 5 months for Wave 1 build (1 backend, 1 frontend). Decision needed by week 4 (mid-June) to start build week 5.

D5 · COOL

Wave 1 = double (FW + QW) or triple (+ PP-preview)?

Triple adds 4 engineering weeks, enables Bayer commercial conversation in July, makes "first-to-market for hayfever" defensibly true on Oct 5, 2026. Decision OK to defer ~2 weeks.

·Change log · what shifted this week

DATE

CHANGE

TYPE

21 MAY 2026

Studio launched. Cloudflare Access wall live · `studio.vantage-otc.com` · authenticated single-user access · concept mockup + launch plan deployed here for review.

NEW

21 MAY 2026

7th module added. Weight Reset Watch™ (terracotta · A08 · Alli sponsor candidate) added to platform. 12-month Gantt extended to 7 rows. Hero triad restructured to 3+4 split.

NEW

21 MAY 2026

Phase 1 markets revised. NL · BE · DE · UK → UK · NL · CH. Switzerland added as premium third market · Belgium and Germany deferred to Phase 2 (post-learnings).

DECISION

21 MAY 2026

Three-role branding locked. Producer (Vantage-OTC Labs · always-on) + OTC sponsor (Claritin / Strepsils / etc.) + Retailer host (Boots Hayfever Pulse / Kruidvat Griep Widget). Each role independent; data identical across all instances.

DECISION

21 MAY 2026

Calendar modules added. Platform expanded from 3 environmental to 6 modules (then 7). Holiday Stomach Watch™ · Sleep Rhythm Watch™ · Quit Watch™ all anchored on calendar (Christmas / DST / Jan 1) rather than weather.

NEW

21 MAY 2026

Pain & fever positioning. Panadol / Nurofen / Advil / Aleve / Aktren — kept OUTSIDE the 7 modules. Sold as Tier 03B cross-module multiplier sponsorship (~€42k/yr/market).

DECISION

21 MAY 2026

Hayfever first-to-market strategy. First-to-market = commercial position, not technical. Bayer Claritin conversation starts July 2026. Pollen Pulse™ ships preview-mode in Oct 2026 · commercial activation Feb 2027.

DECISION

21 MAY 2026

10 sponsor + retailer logos staged. Claritin · Strepsils · Lemsip · Benadryl · Boots · Vicks · Panadol · Vantage-OTC Labs · Nurofen · Aleve. Pending: Nivea · Advil · Aktren · Kruidvat · Gaviscon · ZzzQuil · NiQuitin · Nicotinell · Nicorette · Alli · XLS Medical · Slimfast.

UPDATE